These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38771037)

  • 1. Evaluation of the Tasso+ blood self-collection device for quantitation of plasma cytomegalovirus (CMV) DNAemia in adult solid organ transplant recipients (SOTr).
    Phan T; Kumar L; Woo M; Sadowska-Klasa A; Castor J; Pepper G; Fisher CE; Limaye AP
    Microbiol Spectr; 2024 Jul; 12(7):e0003024. PubMed ID: 38771037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients.
    Helary M; Schnepf N; Mahjoub N; Lacroix M; Xhaard A; Divard G; Delaugerre C; Biard L; LeGoff J; Feghoul L
    J Clin Virol; 2024 Oct; 174():105690. PubMed ID: 38852538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Pascual T; Solano C; Torres I; Talaya A; Giménez E; Vinuesa V; Piñana JL; Hernández-Boluda JC; Pérez A; Navarro D
    J Med Virol; 2018 Aug; 90(8):1375-1382. PubMed ID: 29663435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay.
    Furione M; Rognoni V; Cabano E; Baldanti F
    J Clin Virol; 2012 Dec; 55(4):317-22. PubMed ID: 22989927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Bravo D; Clari MÁ; Costa E; Muñoz-Cobo B; Solano C; José Remigia M; Navarro D
    J Clin Microbiol; 2011 Aug; 49(8):2899-904. PubMed ID: 21697323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of progression and clearance of low-level CMV DNAemia in solid organ transplant recipients.
    Natori Y; Alghamdi A; Husain S; Rotstein C; Selzner N; Tikkanen J; Schiff J; Humar A; Kumar D
    Transpl Infect Dis; 2020 Feb; 22(1):e13207. PubMed ID: 31677321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.
    Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z
    Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
    Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
    J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?
    Fernández-García OA; Hernandez C; Robbins M; Kabbani D; Doucette K; Cervera C
    Transpl Infect Dis; 2024 Aug; 26(4):e14292. PubMed ID: 38728099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients.
    Ahn R; Schaenman J; Qian Z; Pickering H; Groysberg V; Rossetti M; Llamas M; Hoffmann A; Gjertson D; Deng M; Bunnapradist S; Reed EF;
    Front Immunol; 2021; 12():750659. PubMed ID: 34867983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.
    Tong Y; Pang XL; Mabilangan C; Preiksaitis JK
    J Infect Dis; 2017 Apr; 215(7):1094-1101. PubMed ID: 28407149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.
    Clari MÁ; Bravo D; Costa E; Muñoz-Cobo B; Solano C; Remigia MJ; Giménez E; Benmarzouk-Hidalgo OJ; Pérez-Romero P; Navarro D
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):207-9. PubMed ID: 23182073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
    Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
    J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
    Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
    Solano C; Giménez E; Piñana JL; Albert E; Vinuesa V; Hernández-Boluda JC; Amat P; Navarro D
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28471073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.